Skip to content

Search

Showing results for "Childhood interstitial lung disease "

Immune checkpoint inhibitor therapy for malignant pleural mesothelioma

Mesothelioma is a rare and universally fatal cancer linked to exposure to asbestos. Until recently, standard of care treatment was chemotherapy; a treatment resulting in a minimal survival extension, and not improved upon for almost twenty years. However, the advent of cancer immunotherapy – and in particular the immune checkpoint inhibitor class of drugs - has resulted in recently approved new treatment options, with more currently under investigation.

Telethon champ visits The Kids

Ten year old Scott has been walking for Telethon since he was four years old and he's now raised a massive $100 thousand for Telethon.

Phage therapy a CF ‘game changer’

Cutting-edge work is offering new hope to children with Cystic Fibrosis.

Rallying together for child health

The Imogen Miranda Suleski Fellowship is an annual award for early-career post-doctoral researchers at The Kids Research Institute Australia.

Illuminate Sundowner 2024

Illuminate Awards are a philanthropic initiative - shining a light on child health research to help all kids lead happy, healthy lives.

Universal protocols for Strep A surveillance set to transform research for world-first vaccine

A global consortium of Group A Streptococcus (Strep A) researchers has launched a series of best practice surveillance protocols designed to unite international research efforts for a world-first Strep A vaccine.

Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis

Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis Individuals with cystic fibrosis (CF)